
We are excited to announce the merger of Syner-G BioPharma Group and Sequoia Biotech Consulting, joining forces to deliver integrated solutions for life sciences.
Read the Press Release | Learn more about Sequoia
We are the world's leading CMC, Regulatory Affairs, and Medical Writing solutions provider for biopharma.



About Syner-g
Who We Are
What We Do
Pharmaceutical Development (CMC)
Pharmaceutical Development (CMC)
Regulatory Strategy & Submissions
Regulatory Strategy & Submissions
Functional Outsourcing Partnerships
Functional Outsourcing Partnerships
Medical Writing
Medical Writing
Quality & Compliance
Quality & Compliance
Our Capabilities
Why Syner-G?
Number of Years of Industry Experienced Sr. Consultants
Number of Employee and
Number of Ph.Ds World-wide
Number of INDs and IND Amendments Filed
Number of Post-Approval Major Supplements
Years As An Organization (aggregate across all Syner-G companies)
Assets Supported
Number of Agency Meetings



Careers
Latest Developments and Insights

The Importance of Stability Studies in CMC Compliance
Stability studies are essential to pharmaceutical development, providing the data needed to make sure drugs remain safe and effective throughout their shelf life. These studies evaluate how environmental factors like temperature, humidity, and light impact a drug’s quality over time.…
Read Full Article

Understanding the FDA’s Evolving Expectations for Biopharma Compliance
The biopharmaceutical industry stands at a pivotal intersection of regulatory evolution and technological advancement. Companies that successfully adapt to these changes while maintaining robust compliance frameworks will be best positioned to deliver innovative therapies to patients safely and efficiently. …
Read Full Article

CMC Considerations for Biotech Startups Entering Clinical Trials
A strong CMC strategy is crucial for biotech startups moving into clinical trials. Regulatory agencies expect detailed documentation to confirm a drug’s safety, consistency, and quality, which means early planning can prevent costly delays. Startups that take a proactive approach…